Characterization of CCK-B/gastrin-like receptors in human gastric carcinoma

International Journal of Oncology

Volumn 12, Issue 2, 1998, Pages 411-419

  Smith, Jill Palmer ^a   Shih, Alan H ^a   Wotring, Michael G ^a   McLaughlin, Patricia J ^a   Zagon, Ian S ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

CCK A receptor; Growth factors; L 365,260; Neoplasia; Peptides

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; CHOLECYSTOKININ B RECEPTOR; GASTRIN; TRITIUM;

ARTICLE; CANCER GROWTH; GROWTH REGULATION; HORMONAL REGULATION; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; RECEPTOR AFFINITY; RECEPTOR DENSITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CARCINOMA;

EID: 0031930855     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.12.2.411     Document Type: Article

References (30)

1. McGuigan JE, Isaza J and Landor JH: Relationships of gastrin dose, serum gastrin, and acid secretion. Gastroenterology 61: 659-666, 1971.
2. Soll AH, Amirian DA, Thomas LP, Reedy TJ and Elashoff JD: Gastrin receptors on isolated canine parietal cells. J Clin Invest 73: 1434-1447, 1984.
3. Takeuchi K, Speir GR and Johnson LR: Mucosal gastrin receptor. I. Assay standardization and fulfillment of receptor criteria. Am J Physiol 237: E284-E294, 1979.
4. Walsh JH, Richardson CT and Fordtron JS: pH dependence of acid secretion and gastrin release in normal and ulcer subjects. J Clin Invest 55: 462-468, 1975.
5. McGuigan JE and Trudeau WL: Serum gastrin concentrations in pernicious anemia. N Engl J Med 282: 358-361, 1970.
6. Ellison EH and Wilson SD: Further observations on factors influencing the symptomatology manifest by patients with Zolliger-Ellison syndrome. In: Gastric Secretion. Shuitka TK, Gilbert LAL and Harrison RC (eds). Pergamon Publ., New York, pp363-369, 1967.
7. Borch K, Renvall H and Liedberg G: Gastric endocrine cell hyperplasia and carcinoid tumors in pernicious anemia. Gastroenterology 88: 638-648, 1985.
8. Rakic S, Hinder RA, Adanja G and De Meester TR: Elevated serum gastrin levels in patients with gastric cancer. J Surg Oncol 47: 79-81, 1991.
9. Watson SA, Durrant LG and Morris DL: Growth promoting effects on human gastric and colonie tumour cells. Br J Cancer 59:554-558, 1989.
10. 3H]L-365,260: a new potent and selective brain cholecystokinin (CCK-B) and gastrin receptor antagonist radioligand. Mol Pharmacol 35: 803-808, 1989.
11. Pointel MK and Hengels KJ: Differential mode of action of high- and low-affinity CCK/gastrin receptor antagonists in growth inhibition of gastrin-responsive human gastric adenocarcinoma cells in vitro. Anticancer Res 13: 715-720, 1993.
12. Kumamoto T: Gastrin receptors in human gastric scirrhous carcinoma. Gastroenterol Jpn 23: 384-389, 1988.
13. Singh P, Rae-Venter B, Townsend CM, Khalil T and Thompson JC: Gastrin receptors in normal and malignant gastrointestinal mucosa: ase-associated changes. Am J Physiol 249: G761-G769, 1985.
14. Weinstock J and Baldwin GS: Binding of gastrin-17 to human gastric carcinoma cell lines. Cancer Res 48: 932-937, 1988.
15. Barranco SC, Townsend CM, Castartelli C, Macik BG, Burger BL, Bocrwinklc WR and Gourlcy WK: Establishment and characterization of an in vitro model system for human adenocarcinoma of the stomach. Cancer Res 43: 1703-1709, 1983.
16. Smith HS: In vitro properties of epithelial cell lines established from human carcinomas and nonmalignant tissue. J Natl Cancer Inst 62: 225-230, 1979.
17. Wank SA, Pisegna JR and De Weerth A: Brain and gastrointestinal cholecystokinin receptor family: structure and functional expression. Proc Natl Acad Sci USA 89: 8691-8695, 1992.
18. Bradford MA: A rapid and sensitive technique for the quantification of microgram amounts of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
19. 3H]-(±)-L-364,718: a new potent, nonpeptide cholecystokinin antagonist radioligand selective for peripheral receptors. Mol Pharmacol 30: 212-217, 1986.
20. Chomczynski P and Sacci N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1989.
21. Ulrich CD, Ferber I, Holicky E, Hadac E, Buell G and Miller LJ: Molecular cloning and functional expression of the human gall bladder cholecystokinin A receptor. Biochem Biophys Res Commun 193: 204-211, 1993.
22. Ito M, Matsui T, Taniguchi T, Tsukamoto T, Muryama T, Arima N, Nakata H, Chiba T and Chihara K: Functional characterization of a human brain cholecystokinin-B receptor; a trophic effect of cholecystokinin and gastrin. J Biol Chem 268: 300-305, 1993.
23. Johnson LR: New aspects of the trophic action of gastrointestinal hormones. Gastroenterology 72: 788-792, 1977.
24. Sirinck KR, Levine BA and Moyer MP: Pcntagastrin stimulates HI vitro growth of normal and malignant human colon epithelial cells. Am J Surg 149: 35-38, 1985.
25. Smith JP and Solomon TE: Effects of gastrin, proglumide, and somatostatin on growth of human colon cancer. Gastroenterology 95: 1541-1548, 1988.
26. Smith JP, Fantaskey AP, Liu G and Zagon IS: Identification of gastrin as a growth peptide in human pancreatic cancer. Am J Physio! 268: R135-R141, 1995.
27. Kumamoto T, Sumii K, Haruma K, Tari A, Tanaka K and Kajiyama G: Gastrin receptors in human gastrointestinal tract and pancreas. Gastroenterol Jpn 24: 109-114, 1989.
28. Smith JP, Rickabaugh C, McLaughlin PJ and Zagon IS: CCK receptors and PANC-I human pancreatic cancer cells. Am J Physiol 265: G149-G155, 1993.
29. Smith JP, Liu G, Soundararajan V, McLaughlin PJ and Zagon IS: Identification and characterization of CCK-B/gastrin receptors in human pancreatic cancer cell lines. Am J Physiol 266: R277-R283, 1994.
30. Remy-Heintz N, Perrier-Meissonnier S, Nonotte I, Laliberté M-F, Chevillard C, Laboisse C and Bali J-P: Evidence for autocrine growth stimulation by a gastrin/CCK-like peptide of the gastric cancer HGT-1 cell line. Mol Cell Endocrinol 93: 23-29, 1993.